Differential discontinuation by covert use status in Kenya.

Covert contraceptive use Discontinuation of contraception Family planning Longitudinal data Partner dynamics Sub-Saharan Africa

Journal

Contraception: X
ISSN: 2590-1516
Titre abrégé: Contracept X
Pays: United States
ID NLM: 101767748

Informations de publication

Date de publication:
2023
Historique:
received: 01 03 2023
revised: 10 10 2023
accepted: 12 10 2023
medline: 6 11 2023
pubmed: 6 11 2023
entrez: 6 11 2023
Statut: epublish

Résumé

Qualitative research suggests that covert users may be more likely to discontinue contraception due to the logistics of discretion and fear of disclosure. This study sought to quantify whether covert users are more likely to discontinue contraception than overt users. We used a national longitudinal survey from Kenya conducted from November 2019/February 2020 to November 2020/April 2021 to test whether the time to discontinuation between covert and overt users still in need of contraception differed using survival analyses over a period of 5 years since method initiation. Multivariate Cox regression results showed there was an interaction with time and covert use on the risk of discontinuation; for every additional month of use, there was an increased risk of discontinuation of covert users compared to overt users (3% increased hazard, These results suggest efforts are needed to support covert users in managing their contraceptive use and for improving contraceptive counseling surrounding covert use. Our findings shed light on the increasing challenge covert users face after approximately the first 2 years of use; covert users require additional follow-up in both research and care provision. Covert users are at a higher risk of discontinuation of contraception while still trying to avoid pregnancy, particularly after the first 2 years of use. Family planning providers and programs must protect access to and maintain the privacy of reproductive services to this population, focusing on follow-up care provision and counseling.

Identifiants

pubmed: 37928365
doi: 10.1016/j.conx.2023.100102
pii: S2590-1516(23)00014-X
pmc: PMC10625140
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100102

Informations de copyright

© 2023 The Author(s).

Déclaration de conflit d'intérêts

None.

Références

Contracept X. 2022 Sep 17;4:100084
pubmed: 36193281
Glob Health Sci Pract. 2021 Dec 21;9(4):948-963
pubmed: 34933989
Stud Fam Plann. 2012 Sep;43(3):213-22
pubmed: 23185864
Cult Health Sex. 2019 Dec;21(12):1439-1451
pubmed: 30762484
BMC Public Health. 2020 Jun 5;20(1):865
pubmed: 32503485
Cult Health Sex. 2015;17(7):842-58
pubmed: 25703101
Contraception. 2016 Jul;94(1):11-7
pubmed: 27018154
Epidemiology. 2016 Jan;27(1):91-7
pubmed: 26484424
Stud Fam Plann. 2022 Dec;53(4):681-693
pubmed: 36134449
Contraception. 2018 Jul;98(1):41-46
pubmed: 29514043
Stud Fam Plann. 1999 Sep;30(3):231-48
pubmed: 10546314
BMC Public Health. 2021 Jul 5;21(1):1316
pubmed: 34225673
Stud Fam Plann. 2022 Sep;53(3):527-548
pubmed: 35767464
Stud Fam Plann. 1997 Mar;28(1):44-53
pubmed: 9097385
Stud Fam Plann. 1998 Dec;29(4):360-72
pubmed: 9919630
PLoS One. 2020 Nov 18;15(11):e0242345
pubmed: 33206705
BMJ Sex Reprod Health. 2020 Oct;46(4):254-269
pubmed: 31826883
Stud Fam Plann. 2023 Jun;54(2):403-429
pubmed: 36723513
Contracept X. 2022 May 06;4:100077
pubmed: 35620730
Sex Reprod Healthc. 2021 Sep;29:100650
pubmed: 34364197
Violence Against Women. 2023 May;29(6-7):1343-1367
pubmed: 36000323
Stud Fam Plann. 2017 Sep;48(3):269-278
pubmed: 28398595
Stud Fam Plann. 2021 Dec;52(4):467-486
pubmed: 34390002
Front Glob Womens Health. 2023 Mar 13;4:1034634
pubmed: 36994242
Nat Biomed Eng. 2019 Mar;3(3):220-229
pubmed: 30948808
Stud Fam Plann. 2018 Jun;49(2):143-157
pubmed: 29845621
Contracept Reprod Med. 2017 Oct 19;2:24
pubmed: 29201429
Reprod Health. 2018 Jun 26;15(1):114
pubmed: 29940996
BMJ Glob Health. 2018 Dec 30;3(6):e000975
pubmed: 30687521
BMC Womens Health. 2016 Jun 06;16:31
pubmed: 27266263
Stud Fam Plann. 2023 Mar;54(1):17-38
pubmed: 36715569
Br J Cancer. 2009 Jun 2;100(11):1806-11
pubmed: 19401693
Stud Fam Plann. 2017 Sep;48(3):293-303
pubmed: 28885679

Auteurs

Dana Sarnak (D)

Department of Population Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.

Shannon N Wood (SN)

Department of Population Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.

Phil Anglewicz (P)

Department of Population Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.

Elizabeth Gummerson (E)

Department of Population Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.

Peter Gichangi (P)

International Centre for Reproductive Health Kenya, Nairobi, Kenya.
Department of Public Health and Primary Care, Ghent University Faculty of Medicine and Health Sciences, Ghent, Belgium.

Mary Thiongo (M)

International Centre for Reproductive Health Kenya, Nairobi, Kenya.

Caroline Moreau (C)

Department of Population Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
Soins et Santé Primaire, CESP Centre for Research in Epidemiology and Population Health U1018, Inserm, Villejuif, France.

Classifications MeSH